PLIANT THERAPEUTICS, INC. PLRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-06-03
Chart by TradingView
3/9
Piotroski F — financial health
-7.54
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $0 | $0 | $1.6M | $9.7M | $7.6M |
| Operating income | -$156.4M | -$228.4M | -$184.1M | -$127.2M | -$97.5M |
| Net income | -$149.3M | -$210.3M | -$161.3M | -$123.3M | -$97.3M |
| Operating cash flow | -$128.3M | -$155.5M | -$116.4M | -$94.6M | -$75.4M |
| Free cash flow | -$128.7M | -$159.4M | -$117.3M | -$96.4M | -$77.4M |
| Total assets | $225.2M | $396.9M | $512.2M | $350.6M | $221.2M |
| Total liabilities | $44.0M | $92.9M | $38.6M | $37.3M | $22.2M |
| Shareholders' equity | $181.2M | $304.1M | $473.6M | $313.3M | $199.1M |
| Ratios | |||||
| Operating margin | — | — | -11654.7% | -1313.4% | -1288.1% |
| Net margin | — | — | -10211.1% | -1273.3% | -1284.5% |
| FCF margin | — | — | -7422.9% | -995.3% | -1022.1% |
| Return on assets | -66.3% | -53.0% | -31.5% | -35.2% | -44.0% |
| Return on equity | -82.4% | -69.2% | -34.1% | -39.4% | -48.9% |
| Debt / equity | 0.00× | 0.10× | 0.02× | 0.03× | 0.00× |
| Current ratio | 12.00 | 10.91 | 17.72 | 14.23 | 12.44 |
| Revenue growth | — | -100.0% | -83.7% | 27.9% | -81.9% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 1,852,842 | $2.3M |
| Point72 Asset Management, L.P. | 47,054 | $59,288 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -7.54 (distress)
- Working capital / assets 0.8
- Retained earnings / assets -3.816
- EBIT / assets -0.694
- Equity / liabilities 4.116
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001746473 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.